Nav: Home

Community interventions needed to close epilepsy treatment gap can be cost-effective

May 31, 2016

Most of epilepsy cases are treatable, yet in many parts of the world, including sub-Saharan Africa where the burden is amongst the world's highest, access to adequate treatment remains low. This results is significant stigma, avoidable harm and large societal costs. A doctoral dissertation from Umeå University suggests using community health workers to provide patient education and monitor medication adherence in a cost-effective way to reduce the epilepsy treatment gap.

"Our study adds to the health community's understanding of the epidemiology of epilepsy in rural South Africa and seriousness of the treatment gap in this context," says Ryan Wagner, researcher at the Department of Public Health and Clinical Medicine, Unit of Epidemiology and Global Health and author of the dissertation.

"Researchers and policymakers must urgently work together to identify interventions, such as the one we propose, that seek to reduce the epilepsy treatment gap and, ultimately, the burden of epilepsy."

Epilepsy is a common neurological disorder that affects 50 million individuals globally and indirectly impacts the lives of at least 500 million family members, friends and teachers of people with epilepsy. A majority of epilepsy cases are treatable with anti-epileptic drugs.

In his research, Ryan Wagner, who has a background in both neuroscience and field-based epidemiology, has followed a number of individuals in rural Agincourt, South Africa. Participants in the study were patients - both with and without epilepsy - within the Agincourt Health and Demographic Surveillance System. Using blood samples, Ryan Wagner and his research colleagues identified people who had epilepsy and determined how many of them were not adequately receiving or taking treatment, often referred to as the treatment gap.

The study results showed that 63 percent of people with epilepsy did not receive adequate treatment and were in fact in urgent need of an intervention. Employing local community health workers to counsel patients and monitor their adherence to medication for epilepsy, the researchers found, would be a cost-effective intervention to reduce the treatment gap, ultimately reducing the disease burden. Concretely, this would mean fewer seizures, improved productivity and likely less money spent on emergency care.

According to Ryan Wagner, recent attention given to epilepsy by the World Health Organization lends important political support and momentum for increased focus on a condition that for too long has been neglected in much of sub-Saharan Africa.

"Using sound epidemiology and population-based research sites, such as Agincourt, disease parameters can be measured and interventions modelled to determine their cost-effectiveness. Continued epilepsy research is essential in order to reduce the treatment gap for some of the world's most vulnerable populations," says Ryan Wagner, who is keen to continue this work in rural South Africa.
-end-
Ryan Wagner has spent the last eight years living and working in rural northeastern South Africa. In addition to his doctoral studies at the Department of Public Health and Clinical Medicine, Ryan is currently the acting Research Manager at the MRC/Wits Agincourt Research Unit within the School of Public Health, Faculty of Health Sciences at the University of the Witwatersrand, Johannesburg. The abovementioned research was supported by the European Union's Marie-Curie International Research Staff Exchange Scheme, the Umeå Centre for Global Health Research at Umeå University, through contributions from FAS and the Swedish Research School in Global Health. Additional support for the fieldwork was provided through the Priority Cost-effective Lessons for Systems Strengthening (PRICELESS) directorate, a sub-award through the University of Washington from the Bill & Melinda Gates Foundation and the Wellcome Trust.

Umea University

Related Epilepsy Articles:

Good news for kids with epilepsy
There's good news for kids with epilepsy. While several new drugs have come out in the last several years for adults with epilepsy, making those drugs available for children and teenagers has been delayed due to the challenges of testing new drugs on children.
People with epilepsy: Tell us about rare risk of death
People with epilepsy want their health care providers to tell them about a rare risk of death associated with the disorder, according to a preliminary study released today that will be presented at the American Academy of Neurology's 69th Annual Meeting in Boston, April 22 to 28, 2017.
New epilepsy gene network identified by scientists
Scientists have discovered a gene network in the brain associated with epilepsy.
Epilepsy -- why do seizures sometimes continue after surgery?
New research from the University of Liverpool, published in the journal Brain, has highlighted the potential reasons why many patients with severe epilepsy still continue to experience seizures even after surgery.
Redox biomarker could predict progression of epilepsy
Approximately 2.9 million people in the United States suffer from epilepsy, according to the CDC.
Many Malaysian children with epilepsy are vitamin D deficient
Long-term use of antiepileptic drugs is a significant risk factor for vitamin D deficiency in children with epilepsy.
Changes in heart activity may signal epilepsy
Researchers at Case Western Reserve University have found that the parasympathetic nervous system modulates breathing and slows the heart rate of sleeping children with epilepsy substantially more than in healthy children.
Few answers in understanding death from epilepsy
To increase understanding of mortality in epilepsy, including SUDEP, Partners Against Mortality in Epilepsy (PAME) unites physicians, scientists, health care professionals, people with epilepsy, caregivers and bereaved family members for a unique conference that facilitates collaboration and spurs action.
New insights into epilepsy drug Retigabine
A study published ahead of print in the Journal of General Physiology has revealed new insights into Retigabine, a known pharmacological treatment for epilepsy.
Are women with epilepsy using effective contraception?
In the largest study of contraceptive practices of women with epilepsy, 30 percent did not use highly effective contraception despite being at higher risk of having children with fetal malformations due to the anti-epilepsy medications they take.

Related Epilepsy Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#529 Do You Really Want to Find Out Who's Your Daddy?
At least some of you by now have probably spit into a tube and mailed it off to find out who your closest relatives are, where you might be from, and what terrible diseases might await you. But what exactly did you find out? And what did you give away? In this live panel at Awesome Con we bring in science writer Tina Saey to talk about all her DNA testing, and bioethicist Debra Mathews, to determine whether Tina should have done it at all. Related links: What FamilyTreeDNA sharing genetic data with police means for you Crime solvers embraced...